bioAffinity Technologies BIAF
NASDAQ BIAF
$3.17 -0.40 (-11.20%)
At close: Oct 22, 2026 · 4:00 PM EDT

bioAffinity Technologies (BIAF) Short-Term Debt repayments (2023 - 2026)

Updated

bioAffinity Technologies (BIAF) reported Short-Term Debt repayments of $46,109 for Q2 2026, down 37.7% from $74,024 a year earlier but up 11.5% from the prior quarter.

Analysis

bioAffinity Technologies (BIAF) Short-Term Debt repayments (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, bioAffinity Technologies' Short-Term Debt repayments came in at $60,316, down 61.2% year-over-year; for FY2023, it was $251,746.

  • Five-year quarterly Short-Term Debt repayments spans a low of -$101,156 in Q3 2025 and a high of $126,096 in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 HCA Healthcare 102.67 Bn 98.68 Bn - -
2 Natera 57.42 Bn 53.11 Bn 485.19 Mn -
3 Quest Diagnostics 27.06 Bn 25.19 Bn 1.03 Bn -
4 Labcorp Holdings 26.94 Bn 24.68 Bn 1.11 Bn 150.00 Mn
5 Tenet Healthcare 22.62 Bn 11.62 Bn - -
6 Guardant Health 21.58 Bn 17.64 Bn 219.03 Mn -
7 Fresenius Medical Care AG 12.91 Bn 4.86 Bn 1.52 Bn -151,107.04
8 BrightSpring Health Services 12.52 Bn 10.85 Bn 492.75 Mn -
9 Encompass Health 12.42 Bn 12.08 Bn - -
10 bioAffinity Technologies 1.11 Mn -18.57 Mn - 46,109.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46,109.00
Mar 31, 2026 41,339.00
Sep 30, 2025 -101,156.00
Jun 30, 2025 74,024.00
Mar 31, 2025 38,927.00
Sep 30, 2023 42,334.00
Jun 30, 2023 126,096.00
Mar 31, 2023 83,316.00
API Access

bioAffinity Technologies Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=BIAF&period=max&api_key=YOUR_API_KEY